newsfilter
← Latest News
Business Wire·

Revance to Participate in Upcoming Investor Conferences

Revance Therapeutics, Inc. (RVNC) today announced that the company will be participating in the following investor conferences. Cowen 44th Annual Healthcare Conference Chief Executive Officer, Mark Foley and Chief